OPEN ACCESS
PEER-REVIEWED
Review
| Published: October 31, 2026
From Dismissal to Distress: Mapping the Psychological Link Between Diagnostic Delay, Medical Invalidation, and Health Anxiety in Polyendocrine Metabolic Ovarian Syndrome (PMOS)
Assistant Professor (Psychology), Sarojini Naidu Government Girls PG Autonomous College, Barkatullah University, Bhopal, Madhya Pradesh, India.
Google Scholar
More about the auther
Professor of Psychology (Retd.), Bhopal, Madhya Pradesh, India.
Google Scholar
More about the auther
DIP: 18.01.037.20261404
DOI: 10.25215/1404.037
ABSTRACT
Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), is a complex endocrine and metabolic condition with reproductive, dermatological, metabolic, and psychological dimensions. In May 2026, an international consensus process published in The Lancet established PMOS as the new name, intended to better represent the condition’s multisystem features and avoid the misleading implication that ovarian cysts define the syndrome (Teede et al., 2026). Alongside clinical management, the diagnostic journey can shape how individuals interpret symptoms, assess health threats, and engage with healthcare. Research on people previously diagnosed with PCOS documents delayed diagnosis, dissatisfaction with information, and challenging healthcare experiences (Gibson-Helm et al., 2017; Soucie et al., 2021). This conceptual review integrates these findings with health psychology and medical sociology to propose a pathway linking diagnostic uncertainty and perceived medical invalidation with disrupted illness representations, reduced trust, health-related worry, bodily monitoring, and varied health-seeking responses. The framework draws particularly on Leventhal’s Common-Sense Model of Self-Regulation and the concepts of testimonial and hermeneutical injustice. It also considers weight stigma, digital health searching, reassurance seeking, and healthcare avoidance. These links are presented as plausible, testable relationships rather than an established causal sequence, because direct PMOS-specific evidence for the entire pathway remains limited. Implications include respectful symptom validation, transparent diagnostic communication, shared decision-making, and psychological support that does not minimise legitimate physical symptoms. Future research should test the proposed model longitudinally and evaluate interventions designed to improve both patient experience and continuity of care.
Keywords
Polyendocrine Metabolic Ovarian Syndrome, PMOS, Polycystic Ovary Syndrome, PCOS, Diagnostic Delay, Medical Invalidation, Health Anxiety, Illness Perceptions, Medical Trust
This is an Open Access Research distributed under the terms of the Creative Commons Attribution License (www.creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any Medium, provided the original work is properly cited.
© 2026, Sharma, U. & Akhtar, J.
Received: October 11, 2026; Revision Received: October 26, 2026; Accepted: October 31, 2026
Article Overview
ISSN 2348-5396
ISSN 2349-3429
18.01.037.20261404
10.25215/1404.037
Download: 0
View: 10
Published in Volume 14, Issue 4, October- December, 2026
